Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Andrea Németh has successfully applied to the John Fell Fund to establish the Oxford Neurodevelopment Consortium (OxNDC).

Neurodevelopmental disorders include intellectual disability, autism, cerebellar ataxias, epilepsies, and many others. Mental health and neurodegenerative disorders may also have developmental antecedents. They are lifelong conditions with few disease-modifying treatments.  

Large-­scale DNA sequencing studies are unravelling the genetic basis of some of these conditions and this is providing exciting new opportunities to study these conditions, especially when combined with other clinical and basic sciences.

The aim of the OxNDC is to bring together all interested clinical and basic scientists working on neurodevelopmental disorders in Oxford. This will include those working in imaging and neuropathology, and those using cellular or animal models as well those using patient cohorts for genetic or other analysis.

The consortium will strengthen existing collaborations; form new collaborations; and share ideas, resources, materials and protocols. It will create a critical mass of clinicians and scientists with a new momentum capable of securing competitive funding, breaking new ground, and identifying potential therapeutic targets.

Get involved

The inaugural meeting of the OxNDC is planned for March. Those interested, including anyone who would like to present their work, can contact andrea.nemeth@ndcn.ox.ac.uk for more information.

Similar stories

Magnetic signatures of the brain characterised in UK Biobank imaging study

A study published this week in Nature Neuroscience demonstrates how studying the magnetic properties of tissue may provide a unique window into brain health and disease.

NICE recommends offering app-based treatment for people with insomnia instead of sleeping pills

Hundreds of thousands of people suffering from insomnia who would usually be prescribed sleeping pills could be offered an app-based treatment programme instead, NICE has said.

Developmental dynamics of the neural crest–mesenchymal axis in creating the thymic microenvironment

A new paper from researchers at the Department of Paediatrics and the Nuffield Department of Clinical Neurosciences has shown that fibroblasts in the thymus, often considered simply as dull “structural” cells, are much more complex than previously thought.

How to use the science of the body clock to improve our sleep and health

Professor Russell Foster has written a new book about circadian neuroscience which is published by Penguin this week. This book review by Jacqueline Pumphrey was first published on the University of Oxford website.

Funding awarded for autoimmune disease research

Dr Kate Attfield awarded project funding by Connect Immune Research and The Lorna and Yuti Chernajovsky Biomedical Research Foundation.